The company is heavily investing in and successfully launching new products with embedded AI, including the inVue Dx cellular analyzer. This rapid adoption and product rollout creates needs for data processing infrastructure, cloud compute for AI models, and specialized engineering services.
Filing excerpt
Beginning in late 2024 we launched our point-of-care cellular analyzer, IDEXX inVue Dx, which automates real-time cytology and blood cell morphology testing.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
sec-10kaiInvestmentGet every 10-K signal for Idexx Laboratories and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Idexx Laboratories this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/fc361146-003f-4697-a3be-866e4f1f4e74 returns this record as JSON. POST /v1/companies/enrich returns every signal for idexx.com.
{
"signal_id": "fc361146-003f-4697-a3be-866e4f1f4e74",
"signal_type": "sec-10k",
"signal_subtype": "aiInvestment",
"detected_at": "2026-02-24T09:21:44.135+00:00",
"company": {
"name": "Idexx Laboratories",
"domain": "idexx.com"
},
"data": {
"detail": "The company is heavily investing in and successfully launching new products with embedded AI, including the inVue Dx cellular analyzer. This rapid adoption and product rollout creates needs for data processing infrastructure, cloud compute for AI models, and specialized engineering services.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Launched AI-powered IDEXX inVue Dx analyzer in late 2024, reaching 6,000 installed units by end of 2025.",
"excerpts": "Beginning in late 2024 we launched our point-of-care cellular analyzer, IDEXX inVue Dx, which automates real-time cytology and blood cell morphology testing.",
"relevance": 0.9,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm",
"filing_date": "2026-02-20",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Target for AI vendors",
"signal_category": "technology",
"technologies_mentioned": [
"AI"
]
}
}
curl https://signals.autobound.ai/v1/signals/fc361146-003f-4697-a3be-866e4f1f4e74 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"idexx.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.